Astera Labs, Inc. Common Stock (ALAB) Stock Forecast
Data as of May 2, 2026Technology · Current price $201.03 (+3.23%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 15, 2026 | Tom O'Malley | Barclays | $165.00 | -17.9% |
| Dec 3, 2025 | Joseph Moore | Morgan Stanley | $210.00 | +4.5% |
| Nov 17, 2025 | Gus Richard | Northland Securities | $175.00 | -12.9% |
| Nov 5, 2025 | Quinn Bolton | Needham | $220.00 | +9.4% |
| Oct 17, 2025 | Tore Svanberg | Stifel Nicolaus | $185.00 | -8.0% |
| Aug 29, 2025 | Joseph Moore | Morgan Stanley | $200.00 | -0.5% |
| Aug 7, 2025 | Tom O'Malley | Barclays | $155.00 | -22.9% |
| May 16, 2025 | Mehdi Hosseini | Susquehanna | $80.00 | -60.2% |
| May 7, 2025 | Suji Desilva | Roth Capital | $100.00 | -50.3% |
| May 7, 2025 | Tom O'Malley | Barclays | $75.00 | -62.7% |
| Nov 5, 2024 | Mark Lipacis | Evercore ISI | $110.00 | -45.3% |
| Nov 5, 2024 | Richard Shannon | Craig-Hallum | $105.00 | -47.8% |
| Nov 5, 2024 | Quinn Bolton | Needham | $100.00 | -50.3% |
| Nov 5, 2024 | Tore Svanberg | Stifel Nicolaus | $100.00 | -50.3% |
| Oct 9, 2024 | Joseph Moore | Morgan Stanley | $74.00 | -63.2% |
| Aug 26, 2024 | Quinn Bolton | Needham | $42.48 | -78.9% |
| Aug 7, 2024 | Blayne Curtis | Jefferies | $65.00 | -67.7% |
| Aug 7, 2024 | Quinn Bolton | Needham | $65.00 | -67.7% |
| Aug 7, 2024 | Joseph Moore | Morgan Stanley | $55.00 | -72.6% |
| Aug 7, 2024 | Tom O'Malley | Barclays | $70.00 | -65.2% |
Top Analysts Covering ALAB
ALAB vs Sector & Market
| Metric | ALAB | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.10 | 2.34 | 2.41 |
| Analyst Count | 10 | 13 | 18 |
| Target Upside | +0.1% | +4072.7% | +14.9% |
| P/E Ratio | 164.78 | 27.73 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.30B | $1.36B | $1.46B | 17 |
| 2027-12-31 | $1.69B | $1.89B | $2.48B | 17 |
| 2028-03-31 | $498M | $518M | $545M | 5 |
| 2028-06-30 | $534M | $556M | $584M | 5 |
| 2028-09-30 | $573M | $596M | $627M | 6 |
| 2028-12-31 | $610M | $636M | $668M | 8 |
| 2029-03-31 | $667M | $694M | $730M | 9 |
| 2029-06-30 | $718M | $748M | $786M | 9 |
| 2029-09-30 | $775M | $807M | $849M | 10 |
| 2029-12-31 | $807M | $840M | $883M | 12 |
| 2030-12-31 | $1.92B | $2.16B | $2.60B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.35 | $2.49 | $2.79 | 14 |
| 2027-12-31 | $3.21 | $3.58 | $4.58 | 14 |
| 2028-03-31 | $0.93 | $0.98 | $1.05 | 7 |
| 2028-06-30 | $1.02 | $1.08 | $1.15 | 7 |
| 2028-09-30 | $1.12 | $1.18 | $1.26 | 12 |
| 2028-12-31 | $1.21 | $1.28 | $1.37 | 7 |
| 2029-03-31 | $1.26 | $1.33 | $1.42 | 6 |
| 2029-06-30 | $1.37 | $1.44 | $1.54 | 9 |
| 2029-09-30 | $1.49 | $1.57 | $1.67 | 6 |
| 2029-12-31 | $1.57 | $1.66 | $1.77 | 8 |
| 2030-12-31 | $3.16 | $3.71 | $4.69 | 5 |
Frequently Asked Questions
What is the analyst consensus for ALAB?
The consensus among 10 analysts covering Astera Labs, Inc. Common Stock (ALAB) is Buy with an average price target of $202.50.
What is the highest price target for ALAB?
The highest price target for ALAB is $220.00, set by Quinn Bolton at Needham on 2025-11-05.
What is the lowest price target for ALAB?
The lowest price target for ALAB is $42.48, set by Quinn Bolton at Needham on 2024-08-26.
How many analysts cover ALAB?
10 analysts have issued ratings for Astera Labs, Inc. Common Stock in the past 12 months.
Is ALAB a buy or sell right now?
Based on 10 analyst ratings, ALAB has a consensus rating of Buy (2.10/5) with a +0.1% upside to the consensus target of $202.50.
What are the earnings estimates for ALAB?
Analysts estimate ALAB will report EPS of $2.49 for the period ending 2026-12-31, with revenue estimated at $1.36B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.